Who
Joseph Anthony Mara Jr.
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Vericel.
In numbers
- Trades disclosed
- 91
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $1.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jan 2021
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $224K5,000 at $44.75 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $224K5,000 at $44.75 | filing |
| 7 May 2026filed 8 May 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $203K5,000 at $40.50 | filing |
| 7 May 2026filed 8 May 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $203K5,000 at $40.50 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —4,625 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $52K1,358 at $38.09 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —4,625 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,625 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,625 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $52K1,358 at $38.25 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,625 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —4,625 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —4,625 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $52K1,358 at $38.09 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —4,625 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $52K1,358 at $38.25 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —46,250 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —46,250 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code A | —18,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.